Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells

Tomotaka Kato(Tokyo Medical and Dental University), Minoru Tanabe(Tokyo Institute of Technology), Daisuke Ban(Tokyo Medical and Dental University), Toshiro Ogura(Tokyo Medical and Dental University), Shinji Tanaka(Tokyo Institute of Technology), Kosuke Ogawa(Kyoto Katsura Hospital), Mikiya Fujii(Tokyo Medical and Dental University), Atsushi Kudo(Tokyo Medical and Dental University), Hiroaki Ono(Saitama Medical University), Keiichi Akahoshi(Tokyo Medical and Dental University)
PLoS ONE
June 10, 2021
Cited by 30


Related Papers